First-quarter sales for Cynosure (NSDQ:CYNO) may have grown by a healthy 19%, but investors still sent share prices down some 2.2% today after the medical aesthetics company missed Wall Street’s expectations by 1 thin dime.
MassDevice Earnings Roundup
LeMaitre Vascular ticks up on 120% Q1 profit jump
Profits soared 120% for LeMaitre Vascular (NSDQ:LMAT) during the 1st quarter on its 2nd consecutive quarter of double-digit sales growth, as the medical device company beat Wall Street’s earnings expectations by a penny.
Hospira slides after taking $134M charge on infusion pump phase-out
Wright Medical slides into Q1 red, still beats The Street
CORRECTED May 2, 2013 at 12:30 p.m. This article originally mis-stated the nature of an expected insurance settlement and of Wright’s adjusted earnings-per-share forecast.
NuVasive’s Q1 sales rise, profits surge as it settles beef with Medtronic
Investors failed to reward NuVasive Inc. (NSDQ:NUVA) for reporting mid-single-digit sales growth and double-digit profit growth during the 1st quarter, sending shares down slightly today on Wall Street after the medical device company lowered its full-year earnings forecast.
Teleflex slides despite Street-beating Q1 numbers, reaffirmed guidance
HeartWare surges after Q1 results skewer expectations
Shares of HeartWare International (NSDQ:HTWR) are up by more than 10% today after the heart pump maker skewered expectations with its 1st-quarter results, reporting nearly 87% top-line growth and paring losses by more than ⅓.
M&A: Bayer buys Conceptus for $1.1 billion
Sluggish results continue to roll in across the med-tech sector
Covidien’s Q2 profits slide 12%
Varian slides amid uncertainty in U.S. and E.U. oncology markets
Varian Medical Systems (NYSE:VAR) was none too pleased with the market for its oncology systems, calling its Q2 revenues for that division "disappointing, particularly in the U.S."